Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

Top Cited Papers
Open Access
Abstract
BackgroundInfluenza-associated morbidity and mortality has not decreased in the last decade, despite increased receipt of vaccine. To improve the imm

This publication has 0 references indexed in Scilit: